Effects of parenteral anticoagulation on outcomes in patients with acute myocardial infarction and high ischemic risk after coronary intervention: a multicenter, observational study

Effects of parenteral anticoagulation on outcomes in patients with acute myocardial infarction and high ischemic risk after coronary intervention

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200057108

Enrollment

Unknown

Registered

2022-02-28

Start date

2022-03-15

Completion date

Unknown

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. Diagnosed as acute myocardial infarction; 3. Patients with high ischemic risk.

Exclusion criteria

Exclusion criteria: 1. Patients with other indications for anticoagulation therapy, such as mechanical valve implantation, pulmonary embolism, lower extremity venous thrombosis, atrial fibrillation, aortic balloon counterpulsation, etc.; 2. Identify major active bleeding; 3. Contraindications to taking dual antiplatelet drugs; 4. Patients undergoing coronary artery bypass graft; 5. After end-stage renal failure or kidney transplantation; 6. Patients who died within 24 hours of admission; 7. There was a malignant tumor, and the life expectancy was not more than 1 year.

Design outcomes

Primary

Measure	Time frame
major adverse cardiovascular events;	—

Countries

China

Contacts

Public ContactLiu Yuanhui

Guangdong Provincial People's Hospital

liuyuanhui@gdph.org.cn+86 13824440637

Outcome results